Game On: Topokine Initiates Late-Stage Trial of XAF5 Ointment for Reining in Undereye Bags
Topokine Therapeutics initiated a Phase 2b/3 trial for XAF5 Ointment for the reduction of undereye bags.
Read MoreTopokine Therapeutics initiated a Phase 2b/3 trial for XAF5 Ointment for the reduction of undereye bags.
Read MoreIan A. Maher, MD, of St Louis received the ASDS Award for Outstanding Service.
Read MoreWhile greater patient awareness and insurance coverage have contributed to greater breast reconstruction rates in the United States, geographic barriers to access this service remain.
Read MoreA new study may provide objective evidence to support the use of “chemodenervation” using botulinum neurotoxin-A to prolong results among patients undergoing dermal filler treatments.
Read MoreNothing but the best in 2016!
Read More